Table 1 Demographic data in all 910 patients with COVID-19 pneumonia and correlation with prognosis in 320 patients
All patients (910) | Stable patients (127/320) | Hospitalized stable patients (93/320) | Patients needed ICU (72/320) | Died (28/320) | P value | |
|---|---|---|---|---|---|---|
Age | ||||||
Median | 55.2 | 36.5 | 42.4 | 51.4 | 57.7 | < 0.01 |
Range | (19–90) | (19–72) | (34–71) | (40–75) | 38–87 | |
Gender | ||||||
Male | 528(58.02%) | 61 (48.03%) | 57 (61.29%) | 38 (52.77%) | 17(60.71%) | > 0.05 |
Female | 382 (41.97%) | 65 (51.18%) | 36 (38.79%) | 34 (47.22%) | 11(39.28%) | |
Clinical | ||||||
Fever | 802 (88.13%) | 102(80.03%) | 87 (93.54%) | 68 (94.44%) | 28 (100%) | 0.651 |
Cough | 765 (84.06%) | 97(76.3%) | 65 (69.89%) | 65 (90.27%) | 26 (92.85%) | 0.45 |
Dyspnea | 412 (45.27%) | 19(14.96) | 56 (60.21%) | 54 (75.00%) | 28(100%) | < 0.05 |
Sore throat | 350 (38.46%) | 28(22.04%) | 38 (40.86%) | 23(31.94%) | 11(39.28%) | 0.541 |
GIT symptoms | 137 (15.05%) | 35(27.55%) | 23 (24.73%) | 18 (25.00%) | 8 (28.57%) | 0.432 |
Muscle pain | 522 (57.36%) | 58 (45.66%) | 54 (58.06%) | 61 (84.72%) | 22 (78.5%) | 0.58 |
Laboratory investigations | ||||||
SP O2 (%) | 91 (62–99) | 93 (80–99) | 88 (75–98) | 72 (80–99) | 69 (62–81) | 0.01 |
Lymphocytes (%) | 14.8% (3.2–49.5) | 15.2(6–49.5) | 12.2(4.4–45.5) | 10.2(5.3–40.5) | 8.2(3.2–11.45) | 0.07 |
CRP (mg/dL) | 13.54 (1.1–52.16) | 7.5(1.1–16.3) | 11.5(8.2–46.3) | 16.5(8.1–36.3) | 18.5(9.1–52.16) | 0.01 |
D-Dimer (mg/L) | 0.95 (0.27–33.2) | 0.71(0.28–9.3) | 0.99 (0.3–15.3) | 1.1 (1.8–7.3) | 2.3(1.21–13.3) | < 0.05 |
Leucocytes (103 µL) | 5.91 (2.1–19.12) | 4.5(3.3–17.2) | 8.5 (2.1–12.2) | 7.5(5.4–19.12) | 11.5(7.3–12.2) | 0.56 |
S creatinine (mg/dL) | 0.87 (0.50–8.26) | 0.75(0.50–1.4) | 0.81(0.61–1.9) | 1.5 (0.80–8.2) | 2.15 (0.50–1.4) | 0.01 |
Bilirubin (mg/dL) | 0.40 (0.2–4.8) | 0.3 (0.2–1.1) | 1.1(0.4–2.1) | 0.8 (1.2–3.1) | 0.9 (1.4–4.8) | 0.65 |
Co-morbidities | ||||||
Diabetes | 166 (18.2%) | 64 (50.39%) | 31 (33.3%) | 49 (68.05%) | 13 (46.4%) | 0.07 |
Hypertension | 171 (18.7%) | 62 (48.81%) | 34 (36.95%) | 57 (79.16%) | 9 (32.1%) | 0.08 |
Heart disease | 49 (5.3%) | 18 (14.17%) | 16 (17.20%) | 11 (15.27%) | 4 (14.28%) | 0.61 |
COPD /chest | 43 (4.7%) | 15 (11.81%) | 12 (12.90%) | 10 (13.8%) | 6 (21.4%) | 0.54 |
Neurological | 31 (3.4%) | 13 (10.23%) | 9 (9.6%) | 5 (6.9%) | 4 (14.2%) | 0.27 |